1. Duan, Jing, Chen, Lin, Gao, Huabin, Shi, Huijuan, Han, Anjia. 2018. GALNT6 suppresses progression of colorectal cancer. In American journal of cancer research, 8, 2419-2435. doi:. https://pubmed.ncbi.nlm.nih.gov/30662801/
2. Zou, Juan, Li, Yukun, Liao, Nianchun, Zeng, Juan, Mo, Zhongcheng. 2022. Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis. In Journal of ovarian research, 15, 30. doi:10.1186/s13048-022-00962-w. https://pubmed.ncbi.nlm.nih.gov/35227296/
3. Sun, Luhaoran, Li, Zeyu, Shu, Peng, Lu, Min. 2024. N-acetylgalactosaminyltransferase GALNT6 is a potential therapeutic target of clear cell renal cell carcinoma progression. In Cancer science, 115, 3320-3332. doi:10.1111/cas.16296. https://pubmed.ncbi.nlm.nih.gov/39105355/
4. Kimura, Ryuichiro, Yoshimaru, Tetsuro, Matsushita, Yosuke, Nakamura, Yusuke, Katagiri, Toyomasa. 2019. The GALNT6‑LGALS3BP axis promotes breast cancer cell growth. In International journal of oncology, 56, 581-595. doi:10.3892/ijo.2019.4941. https://pubmed.ncbi.nlm.nih.gov/31894262/
5. Noda, Masaru, Okayama, Hirokazu, Tachibana, Kazunoshin, Ohki, Shinji, Kono, Koji. 2018. Glycosyltransferase Gene Expression Identifies a Poor Prognostic Colorectal Cancer Subtype Associated with Mismatch Repair Deficiency and Incomplete Glycan Synthesis. In Clinical cancer research : an official journal of the American Association for Cancer Research, 24, 4468-4481. doi:10.1158/1078-0432.CCR-17-3533. https://pubmed.ncbi.nlm.nih.gov/29844132/
智鼠故事 
